Cidara Therapeutics Stock In The News
| CDTX Stock | USD 22.05 0.31 1.39% |
Our overall analysis of Cidara Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Cidara Therapeutics. The specific impact of Cidara Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Cidara Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Cidara Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Cidara Therapeutics Backtesting and Cidara Therapeutics Hype Analysis. For more information on how to buy Cidara Stock please use our How to Invest in Cidara Therapeutics guide.
Cidara |
Cidara Therapeutics Today Top News and Investor Outlook
Cidara Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Cidara and other traded companies coverage with news coverage. We help investors stay connected with Cidara headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Cidara Stock performance. Please note that trading solely based on the Cidara Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Cidara Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Cidara earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Cidara Therapeutics that are available to investors today. That information is available publicly through Cidara media outlets and privately through word of mouth or via Cidara internal channels. However, regardless of the origin, that massive amount of Cidara data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cidara Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cidara Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cidara Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cidara Therapeutics alpha.
Cidara Largest EPS Surprises
Earnings surprises can significantly impact Cidara Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-03-23 | 2022-12-31 | -0.17 | -0.19 | -0.02 | 11 | ||
2024-03-27 | 2023-12-31 | -0.1 | -0.04 | 0.06 | 60 | ||
2023-11-02 | 2023-09-30 | -0.16 | -0.09 | 0.07 | 43 | ||
2023-05-11 | 2023-03-31 | -0.04 | 0.03 | 0.07 | 175 | ||
2022-03-07 | 2021-12-31 | -0.34 | -0.26 | 0.08 | 23 | ||
2019-08-08 | 2019-06-30 | -0.57 | -0.49 | 0.08 | 14 |
Cidara Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Cidara Therapeutics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
13th of March 2025
Cidara therapeutics chief scientific officer sells shares worth 38,9 - Investing.com at news.google.com
6th of March 2025
Cidara Therapeutics GAAP EPS of -5.37 misses by 1.52 at seekingalpha.com
4th of March 2025
Trading Signals - Stock Traders Daily at news.google.com
20th of February 2025
Cidara Therapeutics, Inc. Sees Significant Increase in Short Interest - MarketBeat at news.google.com
30th of January 2025
Inside Cidaras Next Move CEO Jeffrey Stein Takes Center Stage at Elite Biotech Conference ... at news.google.com
21st of January 2025
Cidara Therapeutics, Inc. Receives 32.20 Consensus Price Target from Analysts - MarketBeat at news.google.com
16th of January 2025
Heres Why Cidara Therapeutics, Inc. Is Skyrocketing - MSN at news.google.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cidara Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cidara Therapeutics' short interest history, or implied volatility extrapolated from Cidara Therapeutics options trading.
Additional Tools for Cidara Stock Analysis
When running Cidara Therapeutics' price analysis, check to measure Cidara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cidara Therapeutics is operating at the current time. Most of Cidara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cidara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cidara Therapeutics' price. Additionally, you may evaluate how the addition of Cidara Therapeutics to your portfolios can decrease your overall portfolio volatility.